Loading...

David Baron, DO

Title(s)Volunteer
SchoolKeck School of Medicine of USC
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Predictors of Major Depressive Disorder in Disaster Survivors
    NIH/NIMH R03MH094822Mar 1, 2014 - Dec 31, 2017
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mennis J, Stahler GJ, El Magd SA, Baron DA. How long does it take to complete outpatient substance use disorder treatment? Disparities among Blacks, Hispanics, and Whites in the US. Addict Behav. 2019 Jan 28; 93:158-165. PMID: 30711669.
      View in: PubMed
    2. Smith KA, Thompson AM, Baron DA, Broadbent ST, Lundstrom GH, Perrone RD. Addressing the Need for Clinical Trial End Points in Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC). Am J Kidney Dis. 2018 Dec 29. PMID: 30600104.
      View in: PubMed
    3. Blum K, Modestino EJ, Badgaiyan RD, Baron D, Thanos PK, Elman I, Siwicki D, Febo M, Gold MS. Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse. EC Psychol Psychiatr. 2018 Aug; 7(8):564-579. PMID: 30417173.
      View in: PubMed
    4. Gold MS, Blum K, Febo M, Baron D, Modestino EJ, Elman I, Badgaiyan RD. Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems. Front Biosci (Schol Ed). 2018 03 01; 10:309-325. PMID: 29293435.
      View in: PubMed
    5. Blum K, Thanos PK, Wang GJ, Febo M, Demetrovics Z, Modestino EJ, Braverman ER, Baron D, Badgaiyan RD, Gold MS. The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis. Curr Pharm Des. 2018 Feb 12; 23(39):6050-6061. PMID: 28831923.
      View in: PubMed
    6. Blum K, Modestino EJ, Gondre-Lewis M, Chapman EJ, Neary J, Siwicki D, Baron D, Hauser M, Smith DE, Roy AK, Thanos PK, Steinberg B, McLaughlin T, Fried L, Barh D, Dunston GA, Badgaiyan RD. The Benefits of Genetic Addiction Risk Score (GARS™) Testing in Substance Use Disorder (SUD). Int J Genom Data Min. 2018; 2018(1). PMID: 30198022.
      View in: PubMed
    7. McLaughlin T, Blum K, Steinberg B, Modestino EJ, Fried L, Baron D, Siwicki D, Braverman ER, Badgaiyan RD. Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD. J Behav Addict. 2018 Mar 01; 7(1):192-203. PMID: 29316800.
      View in: PubMed
    8. Blum K, Modestino EJ, Neary J, Gondré-Lewis MC, Siwicki D, Moran M, Hauser M, Braverman ER, Baron D, Steinberg B, Laughlin TM, Badgaiyan RD. Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis. Biomed J Sci Tech Res. 2018 Jan 07; 2(2):1-4. PMID: 30370423.
      View in: PubMed
    9. Blum K, Chen ALC, Thanos PK, Febo M, Demetrovics Z, Dushaj K, Kovoor A, Baron D, Smith DE, Roy AK, Fried L, Chen TJH, Chapman E, Modestino EJ, Steinberg B, Badgaiyan RD. Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence. Front Biosci (Elite Ed). 2018 01 01; 10:175-196. PMID: 28930612.
      View in: PubMed
    10. McLaughlin T, Blum K, Steinberg B, Siwicki D, Campione J, Badgaiyan RD, Braverman ER, Modestino EJ, Gondré-Lewis MC, Baron D, Mash DC, Giordano J, Thanos PK. Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: "Born Bad". J Reward Defic Syndr Addict Sci. 2017; 3(2):28-31. PMID: 29963654.
      View in: PubMed
    11. North CS, Baron D, Chen AF. Prevalence and predictors of postdisaster major depression: Convergence of evidence from 11 disaster studies using consistent methods. J Psychiatr Res. 2018 Jul; 102:96-101. PMID: 29631191.
      View in: PubMed
    12. Blum K, Han D, Modestino EJ, Saunders S, Roy AK, Jacobs W, Inaba DS, Baron D, Oscar-Berman M, Hauser M, Badgaiyan RD, Smith DE, Femino J, Gold MS. A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone. Subst Use Misuse. 2018 01 28; 53(2):220-229. PMID: 29257919.
      View in: PubMed
    13. Blum K, Modestino EJ, Gondré-Lewis M, Downs BW, Baron D, Steinberg B, Siwicki D, Giordano J, McLaughlin T, Neary J, Hauser M, Fried L, Badgaiyan RD. "Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic. J Syst Integr Neurosci. 2017 11; 3(6). PMID: 30197787.
      View in: PubMed
    14. Blum K, Badgaiyan RD, Dunston GM, Baron D, Modestino EJ, McLaughlin T, Steinberg B, Gold MS, Gondré-Lewis MC. The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer's in Aging African-Americans. Mol Neurobiol. 2018 Jul; 55(7):5526-5536. PMID: 28965318.
      View in: PubMed
    15. Blum K, Gold M, Demetrovics Z, Archer T, Thanos PK, Baron D, Badgaiyan RD. Substance use disorder a bio-directional subset of reward deficiency syndrome. Front Biosci (Landmark Ed). 2017 06 01; 22:1534-1548. PMID: 28410131.
      View in: PubMed
    16. Blum K, Modestino EJ, Febo M, Steinberg B, McLaughlin T, Fried L, Baron D, Siwicki D, Badgaiyan RD. Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission. J Syst Integr Neurosci. 2017 May; 3(3). PMID: 28736624.
      View in: PubMed
    17. Blum K, Febo M, Fried L, Baron D, Braverman ER, Dushaj K, Li M, Demetrovics Z, Badgaiyan RD. Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS). J Reward Defic Syndr Addict Sci. 2017; 3(1):3-13. PMID: 28804788.
      View in: PubMed
    18. Blum K, Fried L, Madigan MA, Giordano J, Modestino EJ, Steinberg B, Baron D, DeLeon M, McLaughlin T, Hauser M, Badgaiyan RD. Critical Analysis of White House Anti-Drug Plan. Glob J Addict Rehabil Med. 2017 Apr; 1(4). PMID: 29057394.
      View in: PubMed
    19. Febo M, Blum K, Badgaiyan RD, Perez PD, Colon-Perez LM, Thanos PK, Ferris CF, Kulkarni P, Giordano J, Baron D, Gold MS. Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z. PLoS One. 2017; 12(4):e0174774. PMID: 28445527.
      View in: PubMed
    20. Blum K, Gold MS, Jacobs W, McCall WV, Febo M, Baron D, Dushaj K, Demetrovics Z, Badgaiyan RD. Neurogenetics of acute and chronic opiate/opioid abstinence: treating symptoms and the cause. Front Biosci (Landmark Ed). 2017 03 01; 22:1247-1288. PMID: 28199203.
      View in: PubMed
    21. Garcia GA, Khoshnevis M, Gale J, Frousiakis SE, Hwang TJ, Poincenot L, Karanjia R, Baron D, Sadun AA. Profound vision loss impairs psychological well-being in young and middle-aged individuals. Clin Ophthalmol. 2017; 11:417-427. PMID: 28260855.
      View in: PubMed
    22. Febo M, Blum K, Badgaiyan RD, Baron D, Thanos PK, Colon-Perez LM, Demortrovics Z, Gold MS. Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. Front Biosci (Landmark Ed). 2017 01 01; 22:669-691. PMID: 27814639.
      View in: PubMed
    23. Radhakrishnan R, Garakani A, Gross LS, Goin MK, Pine J, Slaby AE, Sumner CR, Baron DA. Neuropsychiatric aspects of concussion. Lancet Psychiatry. 2016 Dec; 3(12):1166-1175. PMID: 27889010.
      View in: PubMed
    24. Stroud C, Dmitriev I, Kashentseva E, Bryan JN, Curiel DT, Rindt H, Reinero C, Henry CJ, Bergman PJ, Mason NJ, Gnanandarajah JS, Engiles JB, Gray F, Laughlin D, Gaurnier-Hausser A, Wallecha A, Huebner M, Paterson Y, O'Connor D, Treml LS, Stannard JP, Cook JL, Jacobs M, Wyckoff GJ, Likins L, Sabbagh U, Skaff A, Guloy AS, Hays HD, LeBlanc AK, Coates JR, Katz ML, Lyons LA, Johnson GC, Johnson GS, O'Brien DP, Duan D, Calvet JP, Gandolfi B, Baron DA, Weiss ML, Webster DA, Karanu FN, Robb EJ, Harman RJ. A One Health overview, facilitating advances in comparative medicine and translational research. Clin Transl Med. 2016 Aug; 5(Suppl 1):26. PMID: 27558513; PMCID: PMC4996801.
    25. Gale J, Khoshnevis M, Frousiakis SE, Karanjia R, Poincenot L, Sadun AA, Baron DA. An International Study of Emotional Response to Bilateral Vision Loss Using a Novel Graphical Online Assessment Tool. Psychosomatics. 2017 Jan - Feb; 58(1):38-45. PMID: 27616023.
      View in: PubMed
    26. Baron DA, Gross LS. Where Are We, and Where Are We Going? An Insider's View…. Psychiatr Clin North Am. 2015 Sep; 38(3):xiii-xiv. PMID: 26300040.
      View in: PubMed
    27. Badre N, Baron D, Gross L, Goin M, Pine J, Slaby A, Sumner C. Psychopharmacologic Management in Integrated Care: Challenges for Residency Education. Acad Psychiatry. 2015 Aug; 39(4):466-9. PMID: 26036347.
      View in: PubMed
    28. Blum K, Febo M, Thanos PK, Baron D, Fratantonio J, Gold M. Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? Mol Neurobiol. 2015 Dec; 52(3):1862-1869. PMID: 25750061; PMCID: PMC4586005.
    29. Baron DA. Why I like being an academic psychiatrist. Acad Psychiatry. 2013 Nov; 37(6):416. PMID: 24185289.
      View in: PubMed
    30. Stahler GJ, Mennis J, Baron DA. Geospatial technology and the "exposome": new perspectives on addiction. Am J Public Health. 2013 Aug; 103(8):1354-6. PMID: 23763413; PMCID: PMC4007888.
    31. Lacy BW, Baron DA, Goin MK, Gross LS, Slaby AE, Sumner CR. Doing nothing is doing something: primary care antidepressant treatment in the era of FDA boxed warnings. J Am Osteopath Assoc. 2013 Feb; 113(2):117-9. PMID: 23412671.
      View in: PubMed
    32. Baron DA, Pato MT, Cyr RL. Treatment of adults with attention-deficit/hyperactivity disorder. J Am Osteopath Assoc. 2011 Nov; 111(11):610-4. PMID: 22104513.
      View in: PubMed
    33. Langford D, Baron D, Joy J, Del Valle L, Shack J. Contributions of HIV infection in the hypothalamus and substance abuse/use to HPT dysregulation. Psychoneuroendocrinology. 2011 Jun; 36(5):710-9. PMID: 21115295; PMCID: PMC3090485.
    34. Baron D, Abolmagd S, Erfan S, El Rakhawy M. Personality of mothers of substance-dependent patients. J Multidiscip Healthc. 2010 Apr 28; 3:29-32. PMID: 21197353; PMCID: PMC3004601.
    35. Joy JA, Julius RJ, Akter R, Baron DA. Assessment of ADHD documentation from candidates requesting Americans With Disabilities Act (ADA) accommodations for the National Board of Osteopathic Medical Examiners COMLEX exam. J Atten Disord. 2010 Sep; 14(2):104-8. PMID: 20424009.
      View in: PubMed
    36. Rasmussen BA, Baron DA, Kim JK, Unterwald EM, Rawls SM. ß-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino Acids. 2011 Feb; 40(2):761-4. PMID: 20383795; PMCID: PMC2988910.
    37. Rawls SM, Baron DA, Kim J. beta-Lactam antibiotic inhibits development of morphine physical dependence in rats. Behav Pharmacol. 2010 Mar; 21(2):161-4. PMID: 20215965; PMCID: PMC2923426.
    38. Baron DA. The gold medal face of ADHD. J Atten Disord. 2010 Jan; 13(4):323-4. PMID: 20008821.
      View in: PubMed
    39. Rawls SM, Zielinski M, Patel H, Sacavage S, Baron DA, Patel D. Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation. Drug Alcohol Depend. 2010 Mar 01; 107(2-3):261-3. PMID: 20004063; PMCID: PMC2921944.
    40. Stahler GJ, Mennis J, Cotlar R, Baron DA. The influence of neighborhood environment on treatment continuity and rehospitalization in dually diagnosed patients discharged from acute inpatient care. Am J Psychiatry. 2009 Nov; 166(11):1258-68. PMID: 19797433.
      View in: PubMed
    41. Werkheiser J, Cowan A, Gomez T, Henry C, Parekh S, Chau S, Baron DA, Rawls SM. Icilin-induced wet-dog shakes in rats are dependent on NMDA receptor activation and nitric oxide production. Pharmacol Biochem Behav. 2009 May; 92(3):543-8. PMID: 19248800.
      View in: PubMed
    42. Durell TM, Pumariega AJ, Rothe EM, Tamayo JM, Baron D, Williams D. Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder. Ann Clin Psychiatry. 2009 Jan-Mar; 21(1):26-37. PMID: 19239830.
      View in: PubMed
    43. Lipkovich I, Adams DH, Mallinckrodt C, Faries D, Baron D, Houston JP. Evaluating dose response from flexible dose clinical trials. BMC Psychiatry. 2008 Jan 07; 8:3. PMID: 18179713; PMCID: PMC2254403.
    44. Baron DA, Martin DM, Abol Magd S. Doping in sports and its spread to at-risk populations: an international review. World Psychiatry. 2007 Jun; 6(2):118-23. PMID: 18235871.
      View in: PubMed
    45. Baron DA. How the AACDP helped me professionally and personally. Acad Psychiatry. 2007 Mar-Apr; 31(2):99-100. PMID: 17344439.
      View in: PubMed
    46. Carr JR, Sholevar EH, Baron DA. Trichotillomania and trichobezoar: a clinical practice insight with report of illustrative case. J Am Osteopath Assoc. 2006 Nov; 106(11):647-52. PMID: 17192451.
      View in: PubMed
    47. Rawls SM, Rodriguez T, Baron DA, Raffa RB. A nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria. Brain Res. 2006 Jul 12; 1099(1):82-7. PMID: 16782070.
      View in: PubMed
    48. Raffa RB, Baron DA, Tallarida RJ. Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria. Eur J Pharmacol. 2006 Jul 01; 540(1-3):200-1. PMID: 16737694.
      View in: PubMed
    49. Antia SX, Sholevar EH, Baron DA. Overdoses and ingestions of second-generation antipsychotics in children and adolescents. J Child Adolesc Psychopharmacol. 2005 Dec; 15(6):970-85. PMID: 16379518.
      View in: PubMed
    50. Salaam K, Carr J, Grewal H, Sholevar E, Baron D. Untreated trichotillomania and trichophagia: surgical emergency in a teenage girl. Psychosomatics. 2005 Jul-Aug; 46(4):362-6. PMID: 16000680.
      View in: PubMed
    51. Rawls SM, Baron DA, Gomez T, Jacobs K, Tallarida RJ. Pronounced hypothermic synergy between systemic baclofen and NOS inhibitor. Eur J Pharmacol. 2004 Oct 19; 502(3):271-2. PMID: 15476754.
      View in: PubMed
    52. Baron DA. Exploring the complex moods of bipolar disorder. J Am Osteopath Assoc. 2004 Jun; 104(6 Suppl 6):S1-2. PMID: 15222638.
      View in: PubMed
    53. Baron DA. Case histories for understanding depression in primary care. J Am Osteopath Assoc. 2003 Aug; 103(8 Suppl 4):S16-8. PMID: 12956253.
      View in: PubMed
    54. Baron DA, Hay DP, Easom HM. Treating patients in primary care: the impact of mood, behavior, and thought disturbances. J Am Osteopath Assoc. 2003 Jul; 103(7):319-29. PMID: 12884944.
      View in: PubMed
    55. Rawls SM, Baron DA, Geller EB, Adler MW. Sigma sites mediate DTG-evoked hypothermia in rats. Pharmacol Biochem Behav. 2002 Nov; 73(4):779-86. PMID: 12213522.
      View in: PubMed
    56. Moss HB, Lynch KG, Hardie TL, Baron DA. Family functioning and peer affiliation in children of fathers with antisocial personality disorder and substance dependence: associations with problem behaviors. Am J Psychiatry. 2002 Apr; 159(4):607-14. PMID: 11925299.
      View in: PubMed
    57. Kochhar S, Nwokike JN, Jankowitz B, Sholevar EH, Abed T, Baron DA. Olanzapine overdose: a pediatric case report. J Child Adolesc Psychopharmacol. 2002; 12(4):351-3. PMID: 12625996.
      View in: PubMed
    58. Baron DA. Response: Lack of osteopathic component in Anxiety supplement. J Am Osteopath Assoc. 1997 Oct 01; 97(10):571B. PMID: 28594967.
      View in: PubMed